Understanding pruritus in systemic disease

Area of Science:

• Dermatology
• Internal Medicine
• Oncology

Background:

• Pruritus (itching) frequently arises from systemic abnormalities rather than primary dermatological conditions.
• Numerous systemic diseases, including renal insufficiency, cholestasis, and various cancers like Hodgkin's lymphoma and solid tumors, can manifest as pruritus.
• Iatrogenic causes, particularly opioid-induced pruritus in palliative care, represent a significant challenge.

Purpose of the Study:

• To review the systemic origins of pruritus.
• To discuss current and potential treatment strategies for systemic pruritus.
• To highlight the need for improved understanding and management of pruritus originating from non-dermatological conditions.

Main Methods:

• Literature review of systemic diseases associated with pruritus.
• Analysis of iatrogenic causes of pruritus, focusing on opioid-induced symptoms.
• Evaluation of current therapeutic approaches, including topical, systemic, and cause-directed treatments.

Main Results:

• Systemic diseases are common causes of pruritus, often requiring management of the underlying condition for relief.
• Opioid-induced pruritus is a notable iatrogenic cause, especially in palliative medicine.
• Limited efficacy of topical treatments necessitates systemic strategies like antidepressants, opioid antagonists, and cholestyramine.

Conclusions:

• Effective management of pruritus often involves addressing the underlying systemic disease.
• When disease progression limits curative treatment, systemic therapies offer alternative management options.
• Further research into the mechanisms of pruritus is crucial for developing more effective treatments.